Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)

This study has been completed.

Study NCT00308139 Information provided by Amylin Pharmaceuticals, Inc.

First Received: March 27, 2006 Last Updated: June 17, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2008
Primary Completion Date:	September 2007 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: June 17, 2011